Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model

Infection and Immunity

Volumn 73, Issue 11, 2005, Pages 7413-7421

  Sayeed, Sameera ^a   Fernandez Miyakawa, M E ^b   Fisher, Derek J ^a   Adams, Vicki ^c   Poon, Rachael ^c   Rood, Julian I ^c   Uzal, Francisco A ^b   McClane, Bruce A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; BACTERIAL TOXIN; BACTERIAL VACCINE; EPSILON TOXIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DOMESTIC ANIMAL; GENOTYPE; LETHALITY; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SUPERNATANT; TOXEMIA; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; CLOSTRIDIUM PERFRINGENS; CULTURE MEDIA, CONDITIONED; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; NEUTRALIZATION TESTS;

EID: 27744563267     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.11.7413-7421.2005     Document Type: Article

References (38)

1. Awad, M. M., D. M. Ellemor, R. L. Boyd, J. J. Emmins, and J. I. Rood. 2001. Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect. Immun. 69:7904-7910.
2. Ba-Thein, W., M. Lyristis, K. Ohtani, I. T. Nisbet, H. Hayashi, J. I. Rood, and T. Shimizu. 1996. The virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens. J. Bacteriol. 178:2514-2520.
3. Billington, S. J., E. U. Wieckowski, M. R. Sarker, D. Bueschel, J. G. Songer, and B. A. McClane. 1998. Clostridium perfringens type E animal enteritis isolates with highly conserved, silent enterotoxin sequences. Infect. Immun. 66:4531-4536.
4. Bueschel, D. M., B. H. Jost, S. J. Billington, H. T. Trinh, and J. G. Songer. 2003. Prevalence of cpb2, encoding beta2 toxin, in Clostridium perfringens field isolates: correlation of genotype with phenotype. Vet. Microbiol. 94:121-129.
5. Bullifent, H. L., A. Moir, and R. W. Titball. 1995. The construction of a reporter system and use for the investigation of Clostridium perfringens gene expression. FEMS Microbiology Lett. 131:99-105.
6. Cheung, J. K., and J. I. Rood. 2000. The VirR response regulator from Clostridium perfringens binds independently to two imperfect direct repeats located upstream of the pfoA promoter. J. Bacteriol. 182:57-66.
7. Collie, R. E., J. F. Kokai-Kun, and B. A. McClane. 1998. Phenotypic characterization of enterotoxigenic Clostridium perfringens isolates from non-foodborne human gastrointestinal diseases. Anaerobe 4:69-79.
8. el Idrissi, A. H., and G. E. Ward. 1992. Evaluation of enzyme-linked immunosorbent assay for diagnosis of Clostridium perfringens enterotoxemias. Vet. Microbiol. 31:389-396.
9. Fisher, D. J., K. Miyamoto, B. Harrision, S. Akimoto, M. R. Sarker, and B. A. McClane. 2005. Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Mol. Microbiol. 56:747-762.
10. Garmory, H. S., N. Chanter, N. P. French, D. Busechel, J. G. Songer, and R. W. Titball. 2000. Occurrence of Clostridium perfringens β2-toxin amongst animals, determined using genotyping and subtyping PCR assays. Epidemiol. Infect. 124:61-67.
11. Gibert, M., C. Jolivet-Reynaud, and M. R. Popoff. 1997. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene 203:65-73.
12. Gill, D. M. 1982, Bacterial toxins: a table of lethal amounts. Microbiol. Rev. 46:86-94.
13. Ginter, A., E. D. Williamson, F. Dessy, P. Coppe, H. Bullifent, A. Howells, and R. Titball. 1996. Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals. Microbiology 142:191-198.
14. Habeeb, A. F. 1969. Studies on epsilon-prototoxin of Clostridium perfringens type D. I. purification methods: evidence for multiple forms of epsilon-prototoxin. Arch. Biochem. Biophys. 130:430-440.
15. Hatheway, C. 1990. Toxigenic clostridia. Clin. Microb. Rev. 3:66-76.
16. Jost, B. H., S. J. Billington, H. T. Trinh, D. M. Bueschel, and J. G. Songer. 2005. Atypical cpb2 genes, encoding beta2-toxin in Clostridium perfringens isolates of nonporcine origin. Infect. Immun. 73:652-656.
17. Kokai-Kun, J. F., J. G. Songer, J. R. Czeczulin, F. Chen, and B. A. McClane. 1994. Comparison of Western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens. J. Clin. Microbiol. 32:2533-2539.
18. McClane, B. A., F. A. Uzal, M. F. Miyakawa, D. Lyerly, and T. Wilkins. 2004. The enterotoxic clostridia. In The prokaryotes: an evolving electronic resource for the microbiological community, 3rd ed., vol. 2004. [Online.] Springer-Verlag, New York, N.Y. http://141.150.157.117:8080/prokPUB /chaprender/jsp/showchap.jsp?chapnum=443.
19. McClane, B. A., and J. I. Rood. 2001. Clostridial toxins involved in human enteric and histotoxic infections, p. 169-209. In H. Bahl and P. Duerre (ed.), Clostridia: biotechnology and medical applications. Wiley-VCH, Weinheim, Germany.
20. McDonel, J. L. 1986. Toxins of Clostridium perfringens types A, B, C, D, and E, p. 477-517. In F. Dorner and H. Drews (ed.), Pharmacology of bacterial toxins. Pergamon Press, Oxford, England.
21. McDonel, J. L., and B. A. McClane. 1988. Production, purification and assay of Clostridium perfringens enterotoxin. Method Enzymol. 165:94-103.
22. Minami, J., S. Katayama, O. Matsushita, C. Matsushita, and A. Okabe. 1997. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol. Immunol. 41:527-535.
23. Miyata, S., O. Matsushita, J. Minami, S. Katayama, S. Shimamoto, and A. Okabe. 2001. Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens ε-toxin in the synaptosomal membrane. J. Biol. Chem. 276:13778-13783.
24. Nagahama, M., H. Iida, and J. Sakurai. 1993. Effect of Clostridium perfringens epsilon toxin on rat isolated aorta. Microbiol. Immunol. 37:447-450.
25. Ohtani, K., S. K. Bhowmik, H. Hayashi, and T. Shimizu. 2002. Identification of a novel locus that regulates expression of toxin genes in Clostridium perfringens. FEMS Microbiol. Lett. 209:109-114.
26. Ohtani, K., H. I. Kawsar, K. Okumura, H. Hayashi, and T. Shimizu. 2003. The VirR/VirS regulatory cascade affects transcription of plasmid-encoded putative virulence genes in Clostridium perfringens. FEMS Microbiol. Lett. 222:137-141.
27. Percival, D., A. D. Shuttleworth, E. D. Williamson, and D. C. Kelly. 1990. Anti-idiotypic antibody-induced protection against Clostridium perfringens type D. Infect. Immun. 58:2487-2492.
28. Petit, L., M. Gilbert, and M. R. Popoff. 1999. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 7:104-110.
29. Sakurai, J., M. Nagahama, and Y. Fujii. 1983. Effect of Clostridium perfringens epsilon toxin on the cardiovascular system of rat. Infect. Immun. 42:1183-1186.
30. Sarker, M. R., R. J. Carman, and B. A. McClane. 1999. Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol. Microbiol. 33:946-958.
31. Singh, U., C. M. Van Itallie, L. L. Mitic, J. M. Anderson, and B. A. McClane. 2000. CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J. Biol. Chem. 275:18407-18417.
32. Sloan, J., T. A. Warner, P. T. Scott, T. L. Bannam, D. I. Berryman, and J. I. Rood. 1992. Construction of a sequenced Clostridium perfringens- Escherichia coli shuttle plasmid. Plasmid 27:207-219.
33. Songer, J. G. 1996. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 9:216-234.
34. Stevens, D. L., J. Mitten, and C. Henry. 1987. Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes. J. Infect. Dis. 156:324-333.
35. Uzal, F. A., M. Ghoddusi, W. R. Kelly, and M. Rozmanec. 1999. Comparison of the effects of Clostridium perfringens type D culture supernatants in ligated intestinal loops of goats and sheep. J. Comp. Pathol. 121:127-138.
36. Waters, M., A. Savoie, H. S. Garmory, D. Bueschel, M. R. Popoff, J. G. Songer, R. W. Titball, B. A. McClane, and M. R. Sarker. 2003. Genotyping and phenotyping of beta2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets. J. Clin. Microbiol. 41:3584-3591.
37. Wen, Q, and B. A. McClane. 2004. Detection of enterotoxigenic Clostridium perfringens type A isolates in American retail foods. Appl. Environ. Microbiol. 70:2685-2691.
38. Wnek, A. P., R. J. Strouse, and B. A. McClane. 1985. Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin. Infect. Immun. 50:442-448.